Trials / Completed
CompletedNCT02168439
Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair
Double Blinded Randomized Controlled Trial of Intranasal Dexmedetomidine Versus Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair in the Emergency Department
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- 1 Year – 5 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this research study is to show superiority of intranasal dexmedetomidine to intranasal midazolam as anxiolysis prior to pediatric laceration repairs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | |
| DRUG | Midazolam |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-04-01
- Completion
- 2016-06-01
- First posted
- 2014-06-20
- Last updated
- 2024-11-14
- Results posted
- 2017-03-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02168439. Inclusion in this directory is not an endorsement.